Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,990 public trials 1,836 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Not Yet Recruiting

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

NCT07225439

Conditions: B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +30 more
Locations: Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center Cleveland, Ohio, United States

Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States

View Trial Details

Not Yet Recruiting

ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia

NCT07420959

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Not Yet Recruiting

Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL

NCT06050850

Conditions: ALL, Childhood, Behavior, Behavior, Health, +12 more
Locations: University of Kansas Medical Center Kansas City, Kansas, United States

Children's Mercy Kansas City Kansas City, Missouri, United States

View Trial Details

Not Yet Recruiting

Family-Focused Study to Support Medication for Opioid Use Disorder

NCT07451197

Conditions: Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Northwestern University Feinberg School of Medicine Chicago, Illinois, United States

University of Wisonsin-Madison Madison, Wisconsin, United States

View Trial Details

Not Yet Recruiting

Lisaftoclax Plus Pirtobrutinib in Relapsed or Refractory Mantle Cell Lymphoma After BTK-Targeted Therapy

NCT07684950

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Not Yet Recruiting

Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia

NCT07682792

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Not Yet Recruiting

Hospital Based Continuous Patient Monitoring System

NCT06739447

Conditions: Appendectomy, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma

NCT07514819

Conditions: Bone Diseases, Bone Neoplasms, Bone Tumor, +24 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Not Yet Recruiting

A Seamless, Adaptive Multiple-Ascending-Dose and Efficacy Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extrapulmonary Manifestations

NCT07680166

Conditions: Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Zanubrutinib Induction Followed by Delayed Fixed-Duration Combination With Sonrotoclax for CLL/SLL：Stop Trial 2.0

NCT07682415

Conditions: CLL / SLL, Chronic Disease, Disease Attributes, +14 more
Locations: Shenzhen Second People's Hospital Shenzhen, Guangdong, China

Henan Cancer Hospital Zhengzhou, Henan, China

The Second Xiangya Hospital of Central South University Changsha, Hunan, China

Jiangsu Province Hospital Nanjing, Jiangsu, China

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions